PhotoCure Announces Positive Final Results of Phase 2b Cevira ® Study
4/10/2013 11:22:31 AM
More...
|
Ipsen In-Licenses from PhotoCure Hexvix(R), the First Approved & Marketed Drug for Improved Detection of Bladder Cancer, a Key Step in the Surgical Resection
9/27/2011 6:46:22 AM
More...
|
PhotoCure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer
9/27/2011 6:11:19 AM
More...
|
PhotoCure Launches Allumera® a New, Dynamic Cosmetic for Achieving Timeless Skin
6/20/2011 11:10:16 AM
More...
|
PhotoCure Announces First Commercial Sale of Allumera(R) in the US
5/27/2011 12:07:25 PM
More...
|
PhotoCure - First Quarter 2011 Results
4/27/2011 10:28:10 AM
More...
|
PhotoCure - British Journal of Urology Publishes Paper on Hexvix(R)
3/18/2011 10:13:11 AM
More...
|
PhotoCure Chairman Erik Engebretsen to Resign from the Board of Directors
2/10/2011 9:47:58 AM
More...
|
PhotoCure Announces Positive Allumera(TM) Trial Results for Delivering Significant Skin Appearance Improvements
2/4/2011 8:13:06 AM
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Acquires Lumacan(TM) from PhotoCure
10/20/2010 9:46:42 AM
More...
|
|